SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense trading volume and heightened community discussion as investors weigh the company's recent acquisition of DZYNE Technologies and rising defense contract activity against significant short-term downward pressure. While retail sentiment remains polarized between long-term confidence in autonomous defense technology and frustration over recent volatility and share dilution, active participants are closely monitoring upcoming earnings and institutional developments for potential trend reversals.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is currently the focus of intensive community debate as retail investors react to persistent regulatory hurdles and potential lawsuits from state Attorneys General attempting to block the massive Warner Bros. Discovery merger. Discussion remains polarized, with many shareholders dismissing the legal challenges as political maneuvering while others express growing frustration over the stock's recent volatility and the uncertainty surrounding the deal's final timeline.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings Inc is currently a focal point for retail traders as they weigh its AI-driven credit lending growth against persistent short-selling pressure and macroeconomic headwinds. The community remains deeply polarized, with active discussions debating whether the stock is an undervalued fintech play with long-term potential or a high-beta 'piece of junk' struggling with volatility and a lack of clear upward momentum.

Shutterstock, Inc. engages in the provision of a global creative platform. The company offers data, distribution, and services. Its contents include images, footage, music, three dimensional (3D) models, and generative artificial intelligence. The company was founded by Jonathan Evan Oringer in 2003 and is headquartered in New York, NY.

Shutterstock Inc

Shutterstock is currently the subject of intense community debate as investors weigh its long-term value against significant market pressure following the recent collapse of its merger with Getty Images. While some participants view the stock as a deeply oversold opportunity due to its foundational revenue and data licensing capabilities, others express skepticism about the company's ability to compete in an AI-driven landscape, leading to divided sentiment regarding its future trajectory.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is facing significant downward pressure and intense debate among investors as it hits historical lows, with community members divided between those aggressively accumulating the dip based on long-term technological potential and critics labeling it a failed project. Sentiment remains heavily polarized by Polkadot 2.0 developments and supply cap narratives, as many participants actively weigh the risks of bag-holding against the prospect of a cyclical reversal.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is surging as investors speculate on potential positive clinical data readouts and upcoming earnings, with high trading volume and strong institutional accumulation fueling momentum. The community is actively discussing the company's deep pipeline and the potential for a significant short squeeze given the substantial short interest currently weighing on the stock.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly (LLY) remains a focal point for investors as it continues to solidify its leadership in the GLP-1 weight-loss and diabetes market, supported by strong revenue growth and a robust pipeline. Community discussions are highly concentrated on the company's aggressive expansion strategy, including significant M&A activity in oncology and neuroscience, as well as bullish sentiment surrounding the potential long-term dominance of its metabolic franchise.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is experiencing extreme volatility as investors weigh the long-term strategic potential of its domestic mining and magnet production against significant downward pressure from institutional selling and dilution concerns. The community is intensely debating whether the stock's recent decline is a buying opportunity driven by geopolitical supply chain risks or if ongoing corporate financing actions signal further technical weakness ahead.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin investors are intensely focused on a pivotal Supreme Court oral argument regarding patent protections and the upcoming first-quarter earnings report. Community sentiment remains polarized, with many shareholders expressing frustration over stagnant performance while debating the potential impact of new drug formulations and clinical trial readouts on long-term value.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community debates its long-term potential amid a recent price dip and speculation surrounding upcoming institutional partnerships and infrastructure milestones. While some investors remain cautious about token supply and market volatility, many are actively using the downturn to accumulate, focusing on the project's real-world payment utility and future adoption metrics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Feed

News

Sentiment

Info

Historical Prices

CLAUNCHConLaunch

Fundamentals

Latest CLAUNCH News